PUBLICATION
Dysregulated Protease Homeostasis Defines Primary FSGS
- Authors
- Schmidt, J., Sopel, N., Rist, C., Ohs, A., Dawid, L., Simm, S., Catanese, L., Rupprecht, H., Jobst-Schwan, T., Lehmann, J., Daniel, C., Kalkhof, S., Schiffer, M., Müller-Deile, J.
- ID
- ZDB-PUB-260331-5
- Date
- 2026
- Source
- Kidney360 7: 487500487-500 (Journal)
- Registered Authors
- Jobst-Schwan, Tilman
- Keywords
- FSGS, biomarkers, nephrotic syndrome, proteomics
- MeSH Terms
- none
- PubMed
- 41910486 Full text @ Kidney360
Citation
Schmidt, J., Sopel, N., Rist, C., Ohs, A., Dawid, L., Simm, S., Catanese, L., Rupprecht, H., Jobst-Schwan, T., Lehmann, J., Daniel, C., Kalkhof, S., Schiffer, M., Müller-Deile, J. (2026) Dysregulated Protease Homeostasis Defines Primary FSGS. Kidney360. 7:487500487-500.
Abstract
Key points Serum proteomics reveals reduced serpin family A member 1 (SERPINA1) in primary FSGS, distinguishing it from other proteinuric kidney diseases. Serpina1 knockdown in zebrafish causes proteinuria and edema, supporting its functional relevance in glomerular disease. SERPINA1 may exert compartment-specific functions, and its decrease may permit protease activity to contribute to podocyte injury in primary FSGS.
Background Primary FSGS (pFSGS) is caused by circulating permeability factors. Despite extensive efforts, no single causative factor or biomarker signature has been identified that reliably predicts disease or therapeutic outcomes across all patients. By using liquid chromatography-mass spectrometry-based proteomics on serum samples from patients with pFSGS, compared with controls, we aimed to identify disease-specific protein signatures.
Methods Liquid chromatography-mass spectrometry-based proteomics analysis was performed on 103 serum samples from 36 patients with pFSGS, 33 patients with other proteinuric diseases, and 34 healthy controls. Selected proteins found to be dysregulated in pFSGS were tested in cell culture experiments in immortalized human podocytes. Knockdown experiments were performed in zebrafish larvae, which were screened for proteinuria, edema, and podocyte marker expression. Immunofluorescent staining on zebrafish sections and patients' kidney biopsies was used to confirm findings.
Results Mass spectrometry of sera from patients revealed a set of 27 proteins specifically affected in pFSGS, including a dysbalance of proteases and protease inhibitors. A subset of younger pFSGS patients with frequent relapses showed a distinct serum protein profile based on 23 dysregulated proteins. From proteomics results, serpin family A member 1 (SERPINA1; α-1-antitrypsin) was selected for further investigations. Urinary SERPINA1 increased across nephrotic syndromes, whereas serum SERPINA1 reduction was specific to pFSGS, suggesting a distinct underlying pathophysiology involving immune modulation, increased protease activity, or systemic depletion. Glomerular SERPINA1 expression was selectively increased in sclerotic lesions, likely reflecting a local compensatory response to protease stress. Podocytes constitutively secreted SERPINA1, with limited adaptive response under protease stress. Finally, systemic Serpina1 knockdown in zebrafish induced edema, proteinuria, and loss of slit diaphragm markers.
Conclusions Our findings support a causal and compartment-specific role of SERPINA1 and suggest that reduced circulating protease inhibitors may shift the local protease-antiprotease balance, potentially facilitating podocyte injury in pFSGS.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping